Zurex Pharma Drug Patent Portfolio
Zurex Pharma owns 1 orange book drug protected by 7 US patents Given below is the list of Zurex Pharma's drug patents along with their expiration dates.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US9844654 | Medical skin applicator apparatus | 24 Apr, 2036 | Active |
US10688291 | Medical skin applicator apparatus | 20 Dec, 2034 | Active |
US8389583 | Antimicrobial compositions and methods of use | 09 Aug, 2029 | Active |
US8703828 | Antimicrobial compositions and methods of use | 23 May, 2028 | Active |
US9629368 | Antimicrobial compositions and methods of use | 23 May, 2028 | Active |
US8226971 | Catheter lock solution comprising citrate and a paraben | 06 May, 2025 | Active |
US9011897 | Catheter lock solution comprising citrate and a paraben | 08 Feb, 2025 | Active |
Latest Legal Activities on Zurex Pharma's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Zurex Pharma.
Activity | Date | Patent Number |
---|---|---|
11.5 yr surcharge- late pmt w/in 6 mo, Small Entity | 06 Mar, 2024 | US8226971 |
Payment of Maintenance Fee, 12th Yr, Small Entity | 06 Mar, 2024 | US8226971 |
Payment of Maintenance Fee, 4th Yr, Small Entity | 26 Dec, 2023 | US10688291 |
Payment of Maintenance Fee, 8th Yr, Small Entity | 05 Oct, 2022 | US9011897 |
Payment of Maintenance Fee, 8th Yr, Small Entity | 06 Oct, 2021 | US8703828 |
Payment of Maintenance Fee, 4th Yr, Small Entity | 21 Jun, 2021 | US9844654 |
Payment of Maintenance Fee, 4th Yr, Small Entity | 25 Sep, 2020 | US9629368 |
Payment of Maintenance Fee, 8th Yr, Small Entity | 21 Aug, 2020 | US8389583 |
Recordation of Patent Grant Mailed
Critical
| 23 Jun, 2020 | US10688291 |
Patent Issue Date Used in PTA Calculation
Critical
| 23 Jun, 2020 | US10688291 |
Email Notification
Critical
| 04 Jun, 2020 | US10688291 |
Issue Notification Mailed
Critical
| 03 Jun, 2020 | US10688291 |
Dispatch to FDC | 26 May, 2020 | US10688291 |
Application Is Considered Ready for Issue
Critical
| 26 May, 2020 | US10688291 |
Issue Fee Payment Verified
Critical
| 22 May, 2020 | US10688291 |
Zurex Pharma's Family Patents
Zurex Pharma Drug List
Given below is the complete list of Zurex Pharma's drugs and the patents protecting them.
1. Zuragard
Zuragard is protected by 7 patents, out of which none have expired yet. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US9844654 | Medical skin applicator apparatus |
24 Apr, 2036
(11 years from now)
| Active |
US10688291 | Medical skin applicator apparatus |
20 Dec, 2034
(10 years from now)
| Active |
US8389583 | Antimicrobial compositions and methods of use |
09 Aug, 2029
(4 years from now)
| Active |
US8703828 | Antimicrobial compositions and methods of use |
23 May, 2028
(3 years from now)
| Active |
US9629368 | Antimicrobial compositions and methods of use |
23 May, 2028
(3 years from now)
| Active |
US8226971 | Catheter lock solution comprising citrate and a paraben |
06 May, 2025
(5 months from now)
| Active |
US9011897 | Catheter lock solution comprising citrate and a paraben |
08 Feb, 2025
(2 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zuragard's drug page